What interviewers actually evaluate

Abbott Laboratories sales interviews test whether candidates understand how selling across a diversified healthcare portfolio creates four structurally different sales models that each require specific expertise – where FreeStyle Libre CGM territory management requires building physician prescribing behavior in endocrinology and primary care, advancing payer access conversations in a still-evolving CGM coverage landscape for type 2 diabetes, and creating patient awareness through advocacy programs that support the product's prescription pull strategy, where Alinity diagnostics capital equipment selling requires navigating the hospital laboratory director, C-suite administrator, and group purchasing organization relationships that govern million-dollar instrument system purchasing decisions with 7-10 year contract commitments, where structural heart selling requires clinical specialists who can work alongside interventional cardiologists in cardiac catheterization laboratories during device implantation procedures while building the peer-to-peer clinical program relationships with structural heart conference faculty that drive procedure adoption, and where Established Pharmaceuticals selling in emerging markets requires commercial representatives who understand country-specific healthcare system access, branded generic prescribing dynamics, and the relationship-based selling model that characterizes pharmaceutical selling in healthcare systems where generic substitution may be less automatic than in the US. Sales at Abbott spans FreeStyle Libre territory management and CGM adoption building (where growing CGM new patient starts in a primary care territory requires identifying primary care physicians who have significant type 2 diabetes patient populations, making the clinical and economic case for CGM in type 2, and supporting the payer access conversations that allow physicians to prescribe Libre to patients whose insurance covers it), Alinity competitive displacement and capital equipment sales (where convincing a hospital laboratory director to replace an incumbent Beckman Coulter or Roche analyzer fleet with Alinity requires building the clinical performance case, structuring the financial proposal against incumbent total cost of ownership, and managing the complex stakeholder navigation between laboratory clinical staff and hospital supply chain administration), structural heart clinical specialist selling (where supporting AVEIR leadless pacemaker and TriClip transcatheter tricuspid repair device adoption requires clinical credibility in the cardiac catheterization laboratory, physician relationship development with interventional cardiologists and cardiac surgeons, and the procedural case support skills that distinguish clinical specialist selling from standard device sales), and FreeStyle Libre payer access and formulary management (where working with pharmacy benefit managers, health plan medical directors, and formulary committees to expand Libre coverage for type 2 diabetes requires understanding the payer economics of CGM, the clinical evidence that supports formulary inclusion, and the contracting structure that makes Libre competitively positioned against Dexcom G7 on payer formularies).

Start your free Abbott Laboratories Sales practice session.

What interviewers actually evaluate

Libre CGM Adoption Building, Alinity Capital Equipment Competitive Displacement, and Multi-Segment Sales Model Management

Abbott sales interviews probe whether candidates understand how selling medical devices across different healthcare sales models requires adaptation of selling approach to the specific customer type, purchase decision process, and clinical value proposition in the FreeStyle Libre behavior change selling requirement (convincing a primary care physician who has never prescribed CGM to start prescribing it for their type 2 patients is a behavior change sale, not a product specification sale – the physician is not comparing Libre against an existing CGM they are already prescribing but changing their entire practice pattern around glucose monitoring, which requires a different sales approach than competitive displacement selling that assumes the behavior already exists), the Alinity capital equipment stakeholder complexity (a hospital laboratory instrument decision involves the laboratory director's clinical and operational assessment, the hospital CFO or supply chain's financial evaluation, the GPO contract scope, and sometimes a value analysis committee review – sales professionals who can map all these stakeholders, identify their individual evaluation criteria, and orchestrate a selling process that addresses each stakeholder's concerns in sequence will close these complex institutional accounts more consistently than those who rely primarily on the laboratory director relationship), and the clinical specialist procedural selling requirement (structural heart clinical specialists who are present in the cath lab during device implantation procedures must provide technical guidance to physicians in a clinical environment where their counsel directly affects patient outcomes, requiring selling professionals with the clinical confidence and procedural knowledge to be genuinely useful in high-stakes procedural settings rather than simply maintaining a commercial presence in the clinical environment).

The type 2 diabetes market development selling dimension requires understanding that most primary care physicians have not historically thought of CGM as appropriate for their type 2 diabetes patients (who may be on oral medications or non-insulin injectables rather than insulin), and that building CGM adoption in type 2 requires sales presentations built on clinical evidence showing CGM benefits for non-insulin users – evidence that Abbott has generated through clinical programs specifically designed to shift physician perception of appropriate CGM candidates.

What gets scored in every session

Specific, sentence-level feedback.

Dimension	What it measures	How to answer
FreeStyle Libre type 2 CGM behavior change selling	Do you understand how to build CGM prescribing behavior in primary care physicians who have not historically prescribed CGM for type 2 diabetes – how to identify the primary care physician segments that have the highest type 2 diabetes patient volume and the greatest openness to adopting CGM-based glucose management, what the clinical evidence presentation looks like for building the case for CGM in type 2 patients on non-insulin therapy, and how to address the physician objection that their type 2 patients' insurance doesn't cover CGM by navigating the payer coverage landscape and identifying covered patient populations? We flag sales answers that describe Libre selling as product specification comparison without engaging with the behavior change selling model that type 2 CGM adoption requires.	Primary care physician segmentation for type 2 CGM adoption opportunity, clinical evidence presentation for CGM benefit in non-insulin type 2 patients, payer coverage objection handling for type 2 CGM prescribing
Alinity capital equipment competitive displacement	Can you describe how to lead a competitive displacement campaign for an Alinity chemistry analyzer against an incumbent Beckman Coulter system at a 500-bed community hospital – how to gain access to the laboratory director when an incumbent vendor relationship may create access barriers, what the total cost of ownership analysis looks like for the Alinity proposal against the incumbent renewal contract, and how to manage the GPO contract scope that may constrain the hospital's purchasing flexibility? We score whether your capital equipment approach engages with the institutional stakeholder complexity and total cost modeling that distinguish diagnostic capital equipment selling from consumable device selling.	Laboratory director access strategy in competitive incumbent relationship, Alinity total cost of ownership proposal against incumbent renewal, GPO contract scope navigation for diagnostic capital equipment purchasing flexibility
Structural heart clinical specialist selling and procedural support	Do you understand how to develop a structural heart program at a cardiac catheterization laboratory – how to identify and prioritize the interventional cardiologists at the targeted facility who have the procedural volume and case complexity to benefit from Abbott's structural heart devices, what the proctoring and training program looks like for supporting a new AVEIR implanting physician through their first cases, and how to build the peer-to-peer referral network among electrophysiologists in a regional health system that drives device case volume to the programs where Abbott has established its clinical relationships? We detect clinical specialist answers that describe procedural device selling as calling on cardiology programs without engaging with the case development, physician training, and procedural volume growth that constitute clinical specialist value creation.	Structural heart program physician segmentation for Abbott device case development, AVEIR implanter training and proctoring program design for new implanting physician support, electrophysiology regional referral network development for case volume growth
Payer access and formulary management for FreeStyle Libre	Can you describe how to work with pharmacy benefit managers and health plan formulary committees to expand FreeStyle Libre coverage for type 2 diabetes patients – how to identify which PBMs and health plans have the most significant type 2 diabetes population coverage gaps for CGM, what the clinical value proposition looks like for a PBM medical director evaluating CGM formulary inclusion in terms of A1C improvement, hypoglycemia reduction, and total diabetes management cost, and how to structure the formulary contracting negotiation that positions Libre competitively against Dexcom G7 on preferred placement? We flag sales answers that describe payer access as a regional manager's responsibility without engaging with the clinical economic modeling and contracting strategy that determine CGM formulary coverage for Abbott's commercial accounts.	Health plan type 2 CGM formulary gap identification and prioritization, CGM clinical economic value proposition for PBM formulary committee, Libre versus Dexcom formulary placement contracting strategy

How a session works

Step 1: Choose an Abbott Laboratories sales scenario – FreeStyle Libre type 2 CGM behavior change selling, Alinity capital equipment competitive displacement, structural heart clinical specialist selling and procedural support, or payer access and formulary management for FreeStyle Libre.

Step 2: The AI interviewer asks realistic Abbott sales questions: how you would develop a strategy to grow FreeStyle Libre prescriptions in a primary care territory where only 12% of eligible type 2 diabetes patients are currently on CGM, including how you identify the highest opportunity physicians, what your first conversation with a non-prescribing primary care physician looks like, and how you handle the objection that "CGM is for insulin-dependent patients, not my metformin patients"; how you would navigate the Alinity competitive displacement opportunity at a regional health system where the laboratory director is interested but the system's GPO has a multi-year agreement with Abbott's competitor that provides pricing leverage to the incumbent and creates a contract barrier to switching; or how you would build a new AVEIR leadless pacemaker program at a community hospital cardiac electrophysiology lab where the current electrophysiologist has no experience with leadless devices and the hospital's supply chain department is asking why it should switch from the incumbent device that already has a GPO contract.

Step 3: You respond as you would in the actual interview. The system scores your answer on type 2 CGM behavior change selling, Alinity capital equipment competitive navigation, structural heart clinical specialist development, and payer access management.

Step 4: You get sentence-level feedback on what demonstrated genuine Abbott multi-segment healthcare sales expertise and what needs stronger type 2 CGM prescribing behavior change strategy or Alinity stakeholder complexity navigation.

Frequently Asked Questions

How does FreeStyle Libre selling differ from other CGM or diabetes device selling?
FreeStyle Libre's primary growth opportunity is in the type 2 diabetes market, where hundreds of millions of patients globally have not historically used CGM. Selling Libre in this market requires behavior change selling – convincing primary care physicians to prescribe a new category of monitoring to patients who have managed glucose with intermittent fingerstick testing or HbA1c monitoring. This differs from type 1 CGM selling, which is largely competitive displacement of patients already using CGM. The type 2 opportunity also involves a payer access component, as CGM coverage for non-insulin type 2 patients has expanded but is still not universal, requiring sales representatives to understand their territory's coverage landscape and help physicians navigate prescribing for covered populations.

What makes Alinity capital equipment selling complex?
Alinity laboratory analyzer systems represent multi-million-dollar capital commitments with 7-10 year contracts and deep integration into the laboratory's workflow, quality systems, and information technology. A hospital laboratory decision to switch from an incumbent platform involves operational risk (reagent system transition, staff retraining, method validation), financial risk (transition costs, contract penalties for early termination of incumbent agreement), and clinical risk (any period of reduced analytical capability during the transition affects patient care). Selling against an entrenched incumbent requires Abbott to make the compelling case that Alinity's performance advantages, total cost of ownership, and long-term support commitment outweigh the transition friction, and then to support the laboratory through a well-managed implementation that validates the decision and creates long-term loyalty.

What does structural heart clinical specialist selling involve?
Abbott's structural heart clinical specialists are among the most technically specialized commercial professionals in medical device sales. They work in cardiac catheterization laboratories alongside interventional cardiologists and cardiac surgeons during procedures involving Abbott devices (TriClip transcatheter tricuspid repair, AVEIR leadless pacemaker, Amplatzer structural heart devices). Their role combines commercial development (building case volume at programs committed to Abbott devices) with technical support (providing procedural guidance, troubleshooting device deployment, and helping physicians optimize their technique). Building a structural heart program requires the clinical specialist to first identify and cultivate the physician relationships, then support new physicians through their initial learning curve cases, and then build the volume and institutional credibility that attracts complex case referrals.

How does payer access work for FreeStyle Libre in the US?
FreeStyle Libre payer access involves two primary channels: pharmacy benefit coverage and medical benefit coverage. Pharmacy benefit coverage allows patients to fill Libre prescriptions at retail pharmacies with drug copays, making access straightforward for patients with commercial insurance and the growing Medicare Part D CGM coverage. Medical benefit coverage applies to Medicare and some Medicaid beneficiaries who receive CGM through durable medical equipment channels. Abbott works with pharmacy benefit managers including CVS Caremark, Express Scripts (now Evernorth), and OptumRx to position Libre on preferred formulary tiers, and with Medicare Advantage plans whose formulary decisions affect the growing Medicare beneficiary CGM market. Formulary positioning determines patient out-of-pocket costs and physician prescribing patterns, making payer access management a critical commercial lever alongside physician selling.

How does Abbott manage commercial operations across four different selling models?
Abbott organizes its commercial operations by segment to allow each sales force to develop the segment-specific selling expertise that its customer base requires. FreeStyle Libre and structural heart have separate commercial organizations within Medical Devices, with different training programs, customer segmentation approaches, and incentive compensation structures. Diagnostics has its own commercial organization focused on laboratory director and hospital administrator relationships. Established Pharmaceuticals has country-level commercial organizations in each market. Corporate marketing and payer access functions provide shared services, but the day-to-day commercial execution is segment-managed. This structure allows each business to optimize its commercial model for its customer type while Abbott maintains shared services (HR, finance, legal, regulatory) that create economies of scale across the portfolio.